What is the difference between Timolol Maleate and Travoprost Ophthalmic Solution?

Timolol Maleate and Travoprost Ophthalmic Solution are both Glaucoma Agents, so they work through the same broad mechanism. They differ in dosing, half-life, side-effect frequency, and how individual patients tolerate them. See the head-to-head sections below for the specifics.

Can Timolol Maleate and Travoprost Ophthalmic Solution be used for the same conditions?

Both medications are prescribed for overlapping indications including benzalkonium chloride and or when use of a preservative-free topical medication is advisable.. Always verify with your prescriber and the current FDA label before switching.

Is Timolol Maleate the same as Travoprost Ophthalmic Solution?

No. Timolol Maleate (Timolol Maleate) and Travoprost Ophthalmic Solution (Travoprost Ophthalmic Solution) are distinct medications. They are sometimes confused because of similar branding or because they treat overlapping conditions, but they have different active ingredients and different safety profiles.

Which has fewer side effects, Timolol Maleate or Travoprost Ophthalmic Solution?

Side-effect frequency varies by individual. The side-effect comparison section on this page shows FAERS-reported events for each drug side by side. FAERS is voluntary reporting, so it reflects what patients and clinicians chose to report, not absolute population risk.

Can I switch from Timolol Maleate to Travoprost Ophthalmic Solution?

Switching medications should always be done under prescriber supervision. The "patient stories" section on this page includes accounts from people who have made the switch and what their transition felt like, but those are individual experiences, not protocols.

Timolol Maleate vs Travoprost Ophthalmic Solution

Compare Timolol Maleate (Timolol Maleate) and Travoprost Ophthalmic Solution (Travoprost Ophthalmic Solution), clinical data, side effects, and patient experiences.

Timolol Maleate

Timolol Maleate · Glaucoma Agent

How it works

Other agent

Approved for

benzalkonium chloride

or when use of a preservative-free topical medication is advisable.

OphthalmicTablet

Travoprost Ophthalmic Solution

Travoprost Ophthalmic Solution · Glaucoma Agent

How it works

12.1 Mechanism of Action Travoprost free acid, a prostaglandin analog is a selective FP prostanoid receptor agonist which is believed to reduce IOP by increasing uveoscleral outflo...

Approved for

See full prescribing information

OphthalmicTablet

Quick Comparison

Timolol MaleateTravoprost Ophthalmic Solution

Drug Class

Glaucoma Agent

Route

Ophthalmic

Half-Life

N/A

FDA Approved

N/A

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

Timolol Maleate

Drug Not Working

1-10%

Fatigue

1-10%

Blurred Vision

1-10%

Dizziness

1-10%

Diarrhea

0.1-1%

Shortness of Breath

0.1-1%

Headache

0.1-1%

Nausea

0.1-1%

Travoprost Ophthalmic Solution

Drug Not Working

1-10%

Fatigue

0.1-1%

Blurred Vision

0.1-1%

Dizziness

0.1-1%

Headache

0.1-1%

Shortness of Breath

0.1-1%

FDA Warnings

Timolol Maleate

WARNINGS As with many topically applied ophthalmic drugs, this drug is absorbed systemically
For example, severe respiratory reactions and cardiac reactions, including death due to bronchospasm in patients with asthma, and rarely death in association with cardiac failure, have been reported following systemic or ophthalmic administration of timolol maleate (see CONTRAINDICATIONS )
, chronic bronchitis, emphysema) of mild or moderate severity, bronchospastic disease, or a history of bronchospastic disease (other than bronchial asthma or a history of bronchial asthma, in which Timolol Maleate Ophthalmic Solution in OCUDOSE is contraindicated [see CONTRAINDICATIONS ]) should, in general, not receive beta-blockers, including Preservative-free Timolol Maleate Ophthalmic Solution in OCUDOSE
This may augment the risk of general anesthesia in surgical procedures

Travoprost Ophthalmic Solution

5 WARNINGS AND PRECAUTIONS • Pigmentation: Pigmentation of the iris, periorbital tissue (eyelid), and eyelashes can occur
004% should be used with caution in aphakic patients, in pseudophakic patients with a torn posterior lens capsule, or in patients with known risk factors for macular edema

Clinical Trial Data

No head-to-head clinical studies found for Timolol Maleate vs Travoprost Ophthalmic Solution.

Timolol Maleate vs Travoprost Ophthalmic Solution: What You Should Know

Key Differences

Both Timolol Maleate and Travoprost Ophthalmic Solution belong to the Glaucoma Agent class. While they share a similar mechanism of action, differences in pharmacokinetics, dosing, and side effect profiles may make one more suitable than the other for individual patients.

Safety Considerations

Timolol Maleate carries 4 FDA warnings. Travoprost Ophthalmic Solution carries 2 FDA warnings. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.

Related Comparisons

Dorzolamide Hydrochloride vs Travoprost Ophthalmic Solution→Dorzolamide Hydrochloride And Timolol Maleate Ophthalmic Solution vs Travoprost Ophthalmic Solution→Latanoprost Ophthalmic Solution vs Travoprost Ophthalmic Solution→Travoprost vs Travoprost Ophthalmic Solution→Brimonidine Tartrate vs Travoprost Ophthalmic Solution→Dorzolamide Hydrochloride Timolol Maleate vs Travoprost Ophthalmic Solution→

Primary sources

Every figure on this comparison links back to its primary source. See data sources and methodology for the full provenance trail.

Timolol Maleate: DailyMed label · FAERS adverse events · ClinicalTrials.gov
Travoprost Ophthalmic Solution: DailyMed label · FAERS adverse events · ClinicalTrials.gov

Loading comparison data...

Timolol Maleate vs Travoprost Ophthalmic Solution

Compare Timolol Maleate (Timolol Maleate) and Travoprost Ophthalmic Solution (Travoprost Ophthalmic Solution), clinical data, side effects, and patient experiences.

Timolol Maleate

Timolol Maleate · Glaucoma Agent

How it works

Other agent

Approved for

benzalkonium chloride

or when use of a preservative-free topical medication is advisable.

OphthalmicTablet

Travoprost Ophthalmic Solution

Travoprost Ophthalmic Solution · Glaucoma Agent

How it works

12.1 Mechanism of Action Travoprost free acid, a prostaglandin analog is a selective FP prostanoid receptor agonist which is believed to reduce IOP by increasing uveoscleral outflo...

Approved for

See full prescribing information

OphthalmicTablet

Quick Comparison

Timolol MaleateTravoprost Ophthalmic Solution

Drug Class

Glaucoma Agent

Route

Ophthalmic

Half-Life

N/A

FDA Approved

N/A

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

Timolol Maleate

Drug Not Working

1-10%

Fatigue

1-10%

Blurred Vision

1-10%

Dizziness

1-10%

Diarrhea

0.1-1%

Shortness of Breath

0.1-1%

Headache

0.1-1%

Nausea

0.1-1%

Travoprost Ophthalmic Solution

Drug Not Working

1-10%

Fatigue

0.1-1%

Blurred Vision

0.1-1%

Dizziness

0.1-1%

Headache

0.1-1%

Shortness of Breath

0.1-1%

FDA Warnings

Timolol Maleate

WARNINGS As with many topically applied ophthalmic drugs, this drug is absorbed systemically
For example, severe respiratory reactions and cardiac reactions, including death due to bronchospasm in patients with asthma, and rarely death in association with cardiac failure, have been reported following systemic or ophthalmic administration of timolol maleate (see CONTRAINDICATIONS )
, chronic bronchitis, emphysema) of mild or moderate severity, bronchospastic disease, or a history of bronchospastic disease (other than bronchial asthma or a history of bronchial asthma, in which Timolol Maleate Ophthalmic Solution in OCUDOSE is contraindicated [see CONTRAINDICATIONS ]) should, in general, not receive beta-blockers, including Preservative-free Timolol Maleate Ophthalmic Solution in OCUDOSE
This may augment the risk of general anesthesia in surgical procedures

Travoprost Ophthalmic Solution

5 WARNINGS AND PRECAUTIONS • Pigmentation: Pigmentation of the iris, periorbital tissue (eyelid), and eyelashes can occur
004% should be used with caution in aphakic patients, in pseudophakic patients with a torn posterior lens capsule, or in patients with known risk factors for macular edema

Clinical Trial Data

No head-to-head clinical studies found for Timolol Maleate vs Travoprost Ophthalmic Solution.

Timolol Maleate vs Travoprost Ophthalmic Solution: What You Should Know

Key Differences

Safety Considerations

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.

Primary sources

Every figure on this comparison links back to its primary source. See data sources and methodology for the full provenance trail.

Timolol Maleate: DailyMed label · FAERS adverse events · ClinicalTrials.gov
Travoprost Ophthalmic Solution: DailyMed label · FAERS adverse events · ClinicalTrials.gov